Implementation of a System-level Tobacco Treatment Intervention
| Status: | Recruiting |
|---|---|
| Conditions: | Lung Cancer, Cancer, Smoking Cessation |
| Therapuetic Areas: | Oncology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/1/2018 |
| Start Date: | June 2016 |
| End Date: | April 2019 |
| Contact: | Mary E Cooley, PhD, RN |
| Email: | mary_cooley@dfci.harvard.edu |
| Phone: | 617-632-5096 |
Implementation of a System-level Tobacco Treatment Intervention in Thoracic Oncology
The proposed study plans to adapt and study the implementation and effectiveness of
integrating Clinical and Community Effort Against Secondhand smoke Exposure (CEASE) into the
thoracic oncology setting using mixed methods.
integrating Clinical and Community Effort Against Secondhand smoke Exposure (CEASE) into the
thoracic oncology setting using mixed methods.
In particular the study aims to see if participants are asked about their smoking status and
what services are offered if someone indicates being a former or current smoker. Findings
from this study will help improve a standard of care at this clinic and allow us to
understand what type of tobacco treatment services are preferred by patients.
- Adaption of CEASE will entail exit interviews with patients and individual interviews
with clinical staff to identify and address facilitators and barriers to the
implementation process.
- Effectiveness of CEASE will be measured through questionnaires & biochemical
verification of smoking status using a pre-test/post-test study design before (usual
care)and after implementation (CEASE)
what services are offered if someone indicates being a former or current smoker. Findings
from this study will help improve a standard of care at this clinic and allow us to
understand what type of tobacco treatment services are preferred by patients.
- Adaption of CEASE will entail exit interviews with patients and individual interviews
with clinical staff to identify and address facilitators and barriers to the
implementation process.
- Effectiveness of CEASE will be measured through questionnaires & biochemical
verification of smoking status using a pre-test/post-test study design before (usual
care)and after implementation (CEASE)
Inclusion Criteria:
- Age ≥ 18
- Have an actual or potential diagnosis of thoracic malignancy
- Able to read and write in English.
- Current or recent former smoker (defined as having smoked within past 6 months)
- Must have an active telephone number.
Exclusion Criteria:
- Former smoker greater than 6 months.
- Have any of the below conditions needing immediate medical intervention
- Hypercalcemia causing lethargy and confusion,
- Acute respiratory distress
- Dehydration
- Hypotension
We found this trial at
2
sites
450 Brookline Ave
Boston, Massachusetts 2215
Boston, Massachusetts 2215
617-632-3000
Principal Investigator: Mary E Cooley, MD
Phone: 617-632-5096
Dana-Farber Cancer Institute Since it’s founding in 1947, Dana-Farber has been committed to providing adults...
Click here to add this to my saved trials
75 Francis street
Boston, Massachusetts 02115
Boston, Massachusetts 02115
(617) 732-5500
Principal Investigator: Raphael Bueno, MD
Phone: 617-732-8148
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
Click here to add this to my saved trials